These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2067598

  • 21. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
    Pozo D, Montilla ML, Guerrero JM, Calvo JR.
    Eur J Pharmacol; 1997 Mar 05; 321(3):379-86. PubMed ID: 9085051
    [Abstract] [Full Text] [Related]

  • 22. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Eur J Pharmacol; 1991 Nov 13; 208(3):207-12. PubMed ID: 1663044
    [Abstract] [Full Text] [Related]

  • 23. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
    Grider JR, Rivier JR.
    J Pharmacol Exp Ther; 1990 May 13; 253(2):738-42. PubMed ID: 2110976
    [Abstract] [Full Text] [Related]

  • 24. On the role of galanin in mediating spinal flexor reflex excitability in inflammation.
    Xu IS, Grass S, Xu XJ, Wiesenfeld-Hallin Z.
    Neuroscience; 1998 Aug 13; 85(3):827-35. PubMed ID: 9639276
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist.
    Lumpkin MD, Mulroney SE, Haramati A.
    Endocrinology; 1989 Mar 13; 124(3):1154-9. PubMed ID: 2492921
    [Abstract] [Full Text] [Related]

  • 26. The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell.
    Evans PD, Villegas J.
    J Exp Biol; 1988 Sep 13; 138():259-69. PubMed ID: 3142961
    [Abstract] [Full Text] [Related]

  • 27. Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea.
    Venugopalan CS, Holmes EP, O'Malley NA.
    J Auton Pharmacol; 1990 Oct 13; 10(5):297-304. PubMed ID: 1964680
    [Abstract] [Full Text] [Related]

  • 28. Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II.
    Cridland RA, Henry JL.
    Neuropeptides; 1988 Jan 13; 11(1):23-32. PubMed ID: 2452992
    [Abstract] [Full Text] [Related]

  • 29. The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.
    Wakade TD, Blank MA, Malhotra RK, Pourcho R, Wakade AR.
    J Physiol; 1991 Dec 13; 444():349-62. PubMed ID: 1688031
    [Abstract] [Full Text] [Related]

  • 30. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat.
    Woolf CJ, Wall PD.
    J Neurosci; 1986 May 13; 6(5):1433-42. PubMed ID: 3711988
    [Abstract] [Full Text] [Related]

  • 31. The effects of intrathecal neuropeptide Y on the spinal nociceptive flexor reflex in rats with intact sciatic nerves and after peripheral axotomy.
    Xu XJ, Hao JX, Hökfelt T, Wiesenfeld-Hallin Z.
    Neuroscience; 1994 Dec 13; 63(3):817-26. PubMed ID: 7534884
    [Abstract] [Full Text] [Related]

  • 32. Intrathecal pituitary adenylate cyclase activating polypeptide facilitates the spinal nociceptive flexor reflex in the rat.
    Xu XJ, Wiesenfeld-Hallin Z.
    Neuroscience; 1996 Jun 13; 72(3):801-4. PubMed ID: 9157325
    [Abstract] [Full Text] [Related]

  • 33. Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea.
    Hakoda H, Ito Y.
    J Physiol; 1990 Sep 13; 428():133-54. PubMed ID: 2172520
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of vasoactive intestinal polypeptide in the internal anal sphincter relaxation of the opossum.
    Nurko S, Rattan S.
    J Clin Invest; 1988 Apr 13; 81(4):1146-53. PubMed ID: 3127424
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
    Takai N, Yoshida Y, Shida T, Kondo E, Ueda Y, Kiyama H, Tohyama M.
    Arch Oral Biol; 1997 Mar 13; 42(3):197-204. PubMed ID: 9188989
    [Abstract] [Full Text] [Related]

  • 38. Fragments of galanin message-associated peptide (GMAP) modulate the spinal flexor reflex in rat.
    Xu XJ, Andell S, Bartfai T, Wiesenfeld-Hallin Z.
    Eur J Pharmacol; 1996 Dec 30; 318(2-3):301-6. PubMed ID: 9016918
    [Abstract] [Full Text] [Related]

  • 39. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.
    Robberecht P, Coy DH, Waelbroeck M, Heiman ML, de Neef P, Camus JC, Christophe J.
    Endocrinology; 1985 Nov 30; 117(5):1759-64. PubMed ID: 2994998
    [Abstract] [Full Text] [Related]

  • 40. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD, McDonald JK.
    Endocrinology; 1989 Mar 30; 124(3):1522-31. PubMed ID: 2537185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.